Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 2 open reading frame 78 (C2orf78) is a protein-coding gene of unknown function in humans, often referred to as "uncharacterized protein C2orf78"[3][4][7][8]. There is currently no evidence to classify it as a therapeutic target such as a receptor, enzyme, transporter, or major regulatory molecule. Its protein product remains poorly understood, and its molecular function, biological process, and involvement in specific protein complexes are mostly uncharacterized[4][7][8]. Expression data suggest it may be present in human tissues, including the testis[6][9], and some recent studies have investigated potential links with male infertility through genetic deletion, suggesting C2orf78 may have a role in spermatogenic development or testis biology, but no function or disease-association has been confirmed[2]. There are no known interacting drugs, mechanisms of action, established biomarkers, or specific safety concerns related to this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 2 open reading frame 78 (C2orf78).